SMTL ID : 8u8x.1

crystal structure of the receptor tyrosine kinase Human HER2 (ERBB2) YVMA mutant kinase domain in complex with inhibitor compound 27

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x W9N: 1-{(1R,3r,5S)-3-[(3M)-4-methyl-3-{3-methyl-4-[(1-methyl-1H-benzimidazol-5-yl)oxy]phenyl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-8-azabicyclo[3.2.1]octan-8-yl}propan-1-one(Covalent)

W9N.1: 21 residues within 4Å: Chain A: L.35, G.36, S.37, V.43, A.60, K.62, V.86, S.96, L.98, L.109, T.111, Q.112, L.113, M.114, C.118, D.121, R.162, L.165, T.175, D.176, F.177 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.35, A:V.43, A:K.62, A:K.62, A:L.98, A:T.175, A:D.176 Hydrogen bonds: A:M.114 Water bridges: A:D.121

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.2: 2 residues within 4Å: Chain A: D.151, R.283 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.283

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 2 residues within 4Å: Chain A: I.274, D.275 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hicken, E.J. et al., Discovery of Potent and Selective Covalent Inhibitors of HER2 WT and HER2 YVMA . J.Med.Chem. (2024)

Release Date

2024-06-12

Peptides

Receptor tyrosine-protein kinase erbB-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Receptor tyrosine-protein kinase erbB-2